We are reshaping men's wellness with Erectile Dysfunction Shockwave Pills, a discreet, clinically inspired solution designed for clinic networks and retail partners. I offer ODM capabilities to tailor formulation, packaging, and regulatory documents to your target market, turning your private-label goals into a ready-to-sell Product. Our approach combines proven shockwave principles with convenient dosage form, backed by quality control at every batch. With customizable packaging, labels, and codes, you can deliver consistent patient experiences while maintaining margins. I support MOQ planning, lead times, and scalable production so you can respond quickly to demand. From R&D alignment to post-launch support, I’m here to help you build a trusted brand in men's health. If you want a dependable supply chain and a premium Product that meets international standards, let’s talk and set up your ODM package today.
Global buyers seek dependable erectile dysfunction shockwave solutions backed by rigorous field service. A pioneer model combines advanced therapy with comprehensive support to ensure device performance, stable outcomes, and minimal downtime. Standardized installation, validation, training, preventive maintenance, and rapid repair enable scalable deployments across regions while clinical insight and proven protocols safeguard safety and regulatory compliance. For procurement, success hinges on quality systems, regulatory alignment, and total cost of ownership. Look for ISO/GMP-like practices, clear service level agreements, regional parts availability, and data-driven performance metrics. Flexible options—remote diagnostics, on-site engineers, and fast parts replenishment—minimize risk and support compliant operation across markets. A true partner aligns development, training, and service with market needs, delivering reliable support and resilient multi-country deployment.
| Dimension | Description | Typical Data | Notes |
|---|---|---|---|
| Intervention Type | The technology used for erectile dysfunction treatment | Low-intensity Extracorporeal Shock Wave Therapy (Li-ESWT) | Non-invasive; acoustic waves delivered to penile tissues |
| Device Type | Category of equipment used in Li-ESWT | Dedicated medical Li-ESWT devices | Non-invasive devices designed for clinical use |
| Application Protocol | Typical treatment schedule and energy settings | 6–12 sessions over 6–12 weeks; energy 0.09–0.25 mJ/mm2; 1,500–3,000 shocks per session | Package varies by device and study design |
| Study Population | Average study size per trial | 20–120 participants per trial | Larger pooled analyses include more participants |
| Follow-Up Duration | Post-treatment observation period | 3–12 months | Durability of effect assessed over time |
| Primary Outcome | Main endpoint evaluated in trials | Change in erectile function measured by IIEF-5 score | Higher scores indicate better function |
| Effect Size | Average improvement in erectile function | IIEF-5 improvement ≈ 3–6 points on average | Varies across studies and baseline severity |
| Safety | Tolerability and adverse events | Mostly mild, transient penile discomfort; rare adverse events | No treatment-related serious adverse events commonly reported |
| Responder Rate | Proportion achieving meaningful improvement | Approximately 40–66% meet predefined criteria (e.g., ≥4-point IIEF-5 increase) | Definition of responder may vary by study |